INTRODUCTION
Undecylenic acid is an unsaturated fatty acid naturally derived from castor oil. It is a colorless to pale yellow liquid with antifungal and antimicrobial properties. Chemically known as 10-undecenoic acid, it contains an 11-carbon chain with one double bond and is widely used in pharmaceuticals, cosmetics, personal care products, and chemical intermediates. It is especially effective against fungal infections of the skin and nails.
MANUFACTURE
It is mainly manufactured from castor oil through the following process:
1.Castor oil is hydrolyzed to obtain ricinoleic acid.
2.Ricinoleic acid undergoes pyrolysis (thermal cracking) to produce undecylenic acid and heptaldehyde as a by-product.
3.The crude product is purified by distillation to obtain high-purity undecylenic acid.
| Synonym(s) | 10-Undecenoic Acid; 10-Henedecenoic Acid; Declid; Desenex; 9-Undecylenic acid |
| CAS no. | 112-38-9 |
| EINECS no. | 203-965-8 |
| Molecular formula | C11H20O2 |
| Molecular weight | 184.28 |
| Structure | ![]() |
APPLICATIONS
| Used as an antifungal agent in creams, ointments, powders, and sprays for treating athlete’s foot, ringworm, and other fungal infections. |
| Used in the manufacture of undecylenate salts and esters for pharmaceutical and cosmetic applications. |
| Acts as an intermediate in perfumes, lubricants, resins, and specialty polymers. |
| Used in personal care products such as deodorants, soaps, and shampoos due to its antimicrobial activity. |
| Utilized in chemical synthesis for plasticizers, surfactants, and specialty chemicals. |
SPECIFICATIONS (USP & In-house)
| Test | Unit | Specification |
|---|---|---|
| Appearance | – | Clear, colorless to pale yellow liquid having a characteristic odor |
| Solubility | – | Practically insoluble in water, Miscible with alcohol, with Chloroform, with Ether, with Benzene & fixed & volatile oils |
| Identification | ||
| A. Spectroscopic identification test-IR spectroscopy | – | The infrared spectrum of sample preparation should exhibit maxima only at the same wavelengths as that of a similar preparation of working standard |
| B. The retention time of the undecylenic acid peak of the sample solution corresponds to that of the standard solution, as obtained in assay | – | Retention time should comply |
| Residue on Ignition | % | NMT 0.15 |
| Water soluble acids | % | NMT 1.0 ml of 0.01N Sodium Hydroxide require for test |
| Specific gravity (at 25ºC) | – | 0.910 – 0.913 |
| Iodine value | gI2/100g | 131 – 138 |
| Assay (by GC) | % | 97.0 – 102.0 |
| Residual solvent | ||
| Methanol | ppm | NMT 3000 |
| Microbiological analysis | ||
| Total microbial count | cfu/gm | Max 100 |
| Escherichia coli | – | Should be absent |
| Salmonella spp | – | Should be absent |
| Pseudomonas aeruginosa | – | Should be absent |
| Staphylococcus aureus | – | Should be absent |
PACKING
25 kg UN approved carboy
STORAGE
Store product in its original container. Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and kept upright to prevent leakage.
REACH status
Not registered
ExSyn offers Undecylenic acid on commercial scales and welcomes enquiries. Our exceptional quality and service will make ExSyn your supplier of choice! If you need additional information or SDS, please contact us.
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
N,N′-Dimethylethylenediamine (DMEDA) is an organic chemical compound belonging to the diamine family. It contains two nitrogen atoms, each bearing a methyl group, connected by a two-carbon chain.
Global shipping costs have climbed to $4,000–$4,500 in October from $2,000–$2,500 in February 2026. Freight rates, which had eased through much of 2025 and early 2026 as the demand-supply balance improved, have rebounded sharply in recent months. The increase has brought shipping costs back into focus for businesses dependent on international cargo movement.
The U.S. Food and Drug Administration (FDA) has finalized guidance outlining how manufacturers should report post-approval manufacturing changes for biosimilar and interchangeable biosimilar products. The guidance provides greater regulatory clarity on changes involving production processes, manufacturing sites, analytical methods, raw materials, and process controls. It aims to ensure product quality while reducing unnecessary regulatory burden.
